Today's After-Hours MoversGevo (NASDAQ: GEVO) 30% LOWER; reported Q2 EPS of ($0.15), versus ($0.66) reported last year. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Jefferies Remains Sidelined on Myriad Genetics (MYGN) Following 4Q August 11, 2016 8:37 AM Imperial Capital Raises Price Target on CyberArk Software (CYBR) to $55 Following 2Q August 11, 2016 7:21 AM Piper Jaffray Remains Bearish on Fossil Group (FOSL) Following 2Q Results and Guidance August 10, 2016 8:37 AM Baird Remains Sidelined on Yelp (YELP) as Local Ad Strength Fuels 2Q Beat August 10, 2016 7:48 AM Mizuho Securities Cuts Price Target on Myriad Genetics (MYGN) to $22 Following 4Q and Guidance August 10, 2016 7:19 AM Leerink Partners Raises price Target on Diplomat Pharmacy (DPLO) to $38 Following Mixed 2Q August 10, 2016 7:07 AM Susquehanna Remains Sidelined on Yelp (YELP) Following Solid 4Q Results August 10, 2016 6:59 AM FBR Capital Cuts Price Target on SolarEdge Technologies (SEDG) Following 4Q Report August 10, 2016 6:53 AM